TD Cowen Reiterates Buy Rating on Monte Rosa Therapeutics (GLUE) Following Expanded Novartis Deal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| (NASDAQ: GLUE) | Delayed: 10.40 -0.44 (4.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.84 | 52 Week High | $ | |||
| Open | $10.94 | 52 Week Low | $ | |||
| Day High | $10.94 | P/E | N/A | |||
| Day Low | $10.40 | EPS | $ | |||
| Volume | 233,394 | |||||
